Cholesterol Medicines
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global RNA Drugs Market Research Report 2024
1 RNA Drugs Market Overview
1.1 Product Overview and Scope of RNA Drugs
1.2 RNA Drugs Segment by Type
1.2.1 Global RNA Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 RNA Drugs Segment by Application
1.3.1 Global RNA Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA Drugs Market Size Estimates and Forecasts
1.4.1 Global RNA Drugs Revenue 2017-2028
1.4.2 Global RNA Drugs Sales 2017-2028
1.4.3 RNA Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 RNA Drugs Market Competition by Manufacturers
2.1 Global RNA Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global RNA Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers RNA Drugs Manufacturing Sites, Area Served, Product Type
2.5 RNA Drugs Market Competitive Situation and Trends
2.5.1 RNA Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest RNA Drugs Players Market Share by Revenue
2.5.3 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA Drugs Retrospective Market Scenario by Region
3.1 Global RNA Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global RNA Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America RNA Drugs Market Facts & Figures by Country
3.3.1 North America RNA Drugs Sales by Country
3.3.2 North America RNA Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe RNA Drugs Market Facts & Figures by Country
3.4.1 Europe RNA Drugs Sales by Country
3.4.2 Europe RNA Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific RNA Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific RNA Drugs Sales by Region
3.5.2 Asia Pacific RNA Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America RNA Drugs Market Facts & Figures by Country
3.6.1 Latin America RNA Drugs Sales by Country
3.6.2 Latin America RNA Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa RNA Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa RNA Drugs Sales by Country
3.7.2 Middle East and Africa RNA Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global RNA Drugs Historic Market Analysis by Type
4.1 Global RNA Drugs Sales Market Share by Type (2017-2022)
4.2 Global RNA Drugs Revenue Market Share by Type (2017-2022)
4.3 Global RNA Drugs Price by Type (2017-2022)
5 Global RNA Drugs Historic Market Analysis by Application
5.1 Global RNA Drugs Sales Market Share by Application (2017-2022)
5.2 Global RNA Drugs Revenue Market Share by Application (2017-2022)
5.3 Global RNA Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer RNA Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Roche RNA Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi-Aventis RNA Drugs Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Abbott Laboratories RNA Drugs Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Arrowhead Pharmaceuticals
6.5.1 Arrowhead Pharmaceuticals Corporation Information
6.5.2 Arrowhead Pharmaceuticals Description and Business Overview
6.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Arrowhead Pharmaceuticals RNA Drugs Product Portfolio
6.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.6 Benitec Biopharma
6.6.1 Benitec Biopharma Corporation Information
6.6.2 Benitec Biopharma Description and Business Overview
6.6.3 Benitec Biopharma RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Benitec Biopharma RNA Drugs Product Portfolio
6.6.5 Benitec Biopharma Recent Developments/Updates
6.7 Calimmune Inc
6.6.1 Calimmune Inc Corporation Information
6.6.2 Calimmune Inc Description and Business Overview
6.6.3 Calimmune Inc RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Calimmune Inc RNA Drugs Product Portfolio
6.7.5 Calimmune Inc Recent Developments/Updates
6.8 Dicerna
6.8.1 Dicerna Corporation Information
6.8.2 Dicerna Description and Business Overview
6.8.3 Dicerna RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Dicerna RNA Drugs Product Portfolio
6.8.5 Dicerna Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Corporation Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Gradalis RNA Drugs Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Quark
6.10.1 Quark Corporation Information
6.10.2 Quark Description and Business Overview
6.10.3 Quark RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Quark RNA Drugs Product Portfolio
6.10.5 Quark Recent Developments/Updates
6.11 RXi
6.11.1 RXi Corporation Information
6.11.2 RXi RNA Drugs Description and Business Overview
6.11.3 RXi RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 RXi RNA Drugs Product Portfolio
6.11.5 RXi Recent Developments/Updates
6.12 Senesco
6.12.1 Senesco Corporation Information
6.12.2 Senesco RNA Drugs Description and Business Overview
6.12.3 Senesco RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Senesco RNA Drugs Product Portfolio
6.12.5 Senesco Recent Developments/Updates
6.13 Silence Therapeutics
6.13.1 Silence Therapeutics Corporation Information
6.13.2 Silence Therapeutics RNA Drugs Description and Business Overview
6.13.3 Silence Therapeutics RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Silence Therapeutics RNA Drugs Product Portfolio
6.13.5 Silence Therapeutics Recent Developments/Updates
6.14 Silenseed
6.14.1 Silenseed Corporation Information
6.14.2 Silenseed RNA Drugs Description and Business Overview
6.14.3 Silenseed RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Silenseed RNA Drugs Product Portfolio
6.14.5 Silenseed Recent Developments/Updates
6.15 Tekmira
6.15.1 Tekmira Corporation Information
6.15.2 Tekmira RNA Drugs Description and Business Overview
6.15.3 Tekmira RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Tekmira RNA Drugs Product Portfolio
6.15.5 Tekmira Recent Developments/Updates
6.16 Alnylam Pharmaceuticals
6.16.1 Alnylam Pharmaceuticals Corporation Information
6.16.2 Alnylam Pharmaceuticals RNA Drugs Description and Business Overview
6.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Alnylam Pharmaceuticals RNA Drugs Product Portfolio
6.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 RNA Drugs Manufacturing Cost Analysis
7.1 RNA Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of RNA Drugs
7.4 RNA Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 RNA Drugs Distributors List
8.3 RNA Drugs Customers
9 RNA Drugs Market Dynamics
9.1 RNA Drugs Industry Trends
9.2 RNA Drugs Market Drivers
9.3 RNA Drugs Market Challenges
9.4 RNA Drugs Market Restraints
10 Global Market Forecast
10.1 RNA Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of RNA Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of RNA Drugs by Type (2023-2028)
10.2 RNA Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of RNA Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of RNA Drugs by Application (2023-2028)
10.3 RNA Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of RNA Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of RNA Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global RNA Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global RNA Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global RNA Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global RNA Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global RNA Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global RNA Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global RNA Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global RNA Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market RNA Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers RNA Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers RNA Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global RNA Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global RNA Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global RNA Drugs Sales Market Share by Region (2017-2022)
Table 17. Global RNA Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global RNA Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America RNA Drugs Sales Market Share by Country (2017-2022)
Table 21. North America RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America RNA Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe RNA Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe RNA Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific RNA Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific RNA Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific RNA Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific RNA Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America RNA Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America RNA Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa RNA Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa RNA Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global RNA Drugs Sales Market Share by Type (2017-2022)
Table 41. Global RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global RNA Drugs Revenue Share by Type (2017-2022)
Table 43. Global RNA Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global RNA Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global RNA Drugs Sales Market Share by Application (2017-2022)
Table 46. Global RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global RNA Drugs Revenue Share by Application (2017-2022)
Table 48. Global RNA Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer RNA Drugs Product
Table 53. Pfizer Recent Developments/Updates
Table 54. Roche Corporation Information
Table 55. Roche Description and Business Overview
Table 56. Roche RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Roche RNA Drugs Product
Table 58. Roche Recent Developments/Updates
Table 59. Sanofi-Aventis Corporation Information
Table 60. Sanofi-Aventis Description and Business Overview
Table 61. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Sanofi-Aventis RNA Drugs Product
Table 63. Sanofi-Aventis Recent Developments/Updates
Table 64. Abbott Laboratories Corporation Information
Table 65. Abbott Laboratories Description and Business Overview
Table 66. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Abbott Laboratories RNA Drugs Product
Table 68. Abbott Laboratories Recent Developments/Updates
Table 69. Arrowhead Pharmaceuticals Corporation Information
Table 70. Arrowhead Pharmaceuticals Description and Business Overview
Table 71. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Arrowhead Pharmaceuticals RNA Drugs Product
Table 73. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 74. Benitec Biopharma Corporation Information
Table 75. Benitec Biopharma Description and Business Overview
Table 76. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Benitec Biopharma RNA Drugs Product
Table 78. Benitec Biopharma Recent Developments/Updates
Table 79. Calimmune Inc Corporation Information
Table 80. Calimmune Inc Description and Business Overview
Table 81. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Calimmune Inc RNA Drugs Product
Table 83. Calimmune Inc Recent Developments/Updates
Table 84. Dicerna Corporation Information
Table 85. Dicerna Description and Business Overview
Table 86. Dicerna RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Dicerna RNA Drugs Product
Table 88. Dicerna Recent Developments/Updates
Table 89. Gradalis Corporation Information
Table 90. Gradalis Description and Business Overview
Table 91. Gradalis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Gradalis RNA Drugs Product
Table 93. Gradalis Recent Developments/Updates
Table 94. Quark Corporation Information
Table 95. Quark Description and Business Overview
Table 96. Quark RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Quark RNA Drugs Product
Table 98. Quark Recent Developments/Updates
Table 99. RXi Corporation Information
Table 100. RXi Description and Business Overview
Table 101. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. RXi RNA Drugs Product
Table 103. RXi Recent Developments/Updates
Table 104. Senesco Corporation Information
Table 105. Senesco Description and Business Overview
Table 106. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Senesco RNA Drugs Product
Table 108. Senesco Recent Developments/Updates
Table 109. Silence Therapeutics Corporation Information
Table 110. Silence Therapeutics Description and Business Overview
Table 111. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Silence Therapeutics RNA Drugs Product
Table 113. Silence Therapeutics Recent Developments/Updates
Table 114. Silenseed Corporation Information
Table 115. Silenseed Description and Business Overview
Table 116. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Silenseed RNA Drugs Product
Table 118. Silenseed Recent Developments/Updates
Table 119. Tekmira Corporation Information
Table 120. Tekmira Description and Business Overview
Table 121. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Tekmira RNA Drugs Product
Table 123. Tekmira Recent Developments/Updates
Table 124. Alnylam Pharmaceuticals Corporation Information
Table 125. Alnylam Pharmaceuticals Description and Business Overview
Table 126. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Alnylam Pharmaceuticals RNA Drugs Product
Table 128. Alnylam Pharmaceuticals Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. RNA Drugs Distributors List
Table 132. RNA Drugs Customers List
Table 133. RNA Drugs Market Trends
Table 134. RNA Drugs Market Drivers
Table 135. RNA Drugs Market Challenges
Table 136. RNA Drugs Market Restraints
Table 137. Global RNA Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 138. Global RNA Drugs Sales Market Share Forecast by Type (2023-2028)
Table 139. Global RNA Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 140. Global RNA Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 141. Global RNA Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 142. Global RNA Drugs Sales Market Share Forecast by Application (2023-2028)
Table 143. Global RNA Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 144. Global RNA Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 145. Global RNA Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 146. Global RNA Drugs Sales Market Share Forecast by Region (2023-2028)
Table 147. Global RNA Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 148. Global RNA Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of RNA Drugs
Figure 2. Global RNA Drugs Market Share by Type in 2021 & 2028
Figure 3. siRNA Product Picture
Figure 4. ASO Product Picture
Figure 5. miRNA Product Picture
Figure 6. Nucleic Acid Aptamers Product Picture
Figure 7. Global RNA Drugs Market Share by Application in 2021 & 2028
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. Global RNA Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global RNA Drugs Market Size (2017-2028) & (US$ Million)
Figure 15. Global RNA Drugs Sales (2017-2028) & (K Units)
Figure 16. RNA Drugs Sales Share by Manufacturers in 2021
Figure 17. Global RNA Drugs Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest RNA Drugs Players: Market Share by Revenue in 2021
Figure 19. RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global RNA Drugs Sales Market Share by Region (2017-2022)
Figure 21. Global RNA Drugs Sales Market Share by Region in 2021
Figure 22. Global RNA Drugs Revenue Market Share by Region (2017-2022)
Figure 23. Global RNA Drugs Revenue Market Share by Region in 2021
Figure 24. U.S. RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Taiwan RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Philippines RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Vietnam RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Mexico RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Brazil RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Argentina RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. U.A.E RNA Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of RNA Drugs by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of RNA Drugs
Figure 50. Manufacturing Process Analysis of RNA Drugs
Figure 51. RNA Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Roche Sanofi-Aventis Abbott Laboratories Arrowhead Pharmaceuticals Benitec Biopharma Calimmune Inc Dicerna Gradalis Quark RXi Senesco Silence Therapeutics Silenseed Tekmira Alnylam Pharmaceuticals